MISHCHENKO, O. Y. .; ADONKINA, V. Y. .; GRESHKO, I. I. The substantiation of the cost optimization for ER(+) HER2(−) breast cancer hormone therapy based on the results of the cost minimization pharmacoeconomic analysis. Social Pharmacy in Health Care, [S. l.], v. 11, n. 1, p. 72–79, 2025. DOI: 10.24959/sphhcj.25.349. Disponível em: http://sphhcj.nuph.edu.ua/article/view/330647. Acesso em: 26 jul. 2025.